Sevelamer Carbonate Tablets Manufacturer in India | CKD Phosphate Binder Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Sevelamer Carbonate Tablets are phosphate-binding medications used in the management of hyperphosphatemia in patients with chronic kidney disease (CKD). The medicine binds dietary phosphate within the gastrointestinal tract, reducing phosphate absorption and helping maintain appropriate serum phosphorus levels. Genliva Wellness LLP is a trusted Sevelamer Carbonate Tablet Manufacturer in India offering high-quality nephrology formulations for domestic and international pharmaceutical markets.

This formulation is widely prescribed for patients undergoing dialysis and those requiring phosphate control as part of renal care management. As a reliable Sevelamer Carbonate Tablet Exporter from India, Genliva Wellness LLP supplies quality-assured pharmaceutical products to healthcare providers and distributors worldwide.

Sevelamer Carbonate plays an important role in renal disease management by helping control phosphorus accumulation associated with impaired kidney function.

Sevelamer Carbonate Tablets are formulated to control phosphate levels in patients with chronic kidney disease.

Contains Sevelamer Carbonate as the active ingredient
Non-calcium phosphate-binding agent
Binds dietary phosphate in the gastrointestinal tract
Reduces phosphate absorption from food
Helps manage elevated serum phosphorus levels

Sevelamer Carbonate Tablets are used in the management of phosphate-related complications in kidney disease.

Hyperphosphatemia
Chronic kidney disease (CKD)
Dialysis patient care
Phosphate control therapy
Renal disease management
Long-term nephrology treatment programs

Sevelamer Carbonate Tablets provide targeted phosphate control for patients with impaired kidney function.

Lowers dietary phosphate absorption
Assists in maintaining phosphorus balance
Supports management of CKD-related complications
Non-calcium phosphate binder option
Addresses phosphate accumulation associated with renal disease
Integrates effectively into dialysis care protocols